1-1 of 1
Bonita Bryant
Close
Sort by
Journal Articles

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52 + T-cell malignancies

Clinical Trials & Observations
Milos D. Miljkovic, Sigrid P. Dubois, Jürgen R. Müller, Bonita Bryant, Elaine Ma, Kevin C. Conlon, Thomas A. Waldmann
Journal: Blood Advances
Blood Adv (2023) 7 (3): 384–394.
https://doi.org/10.1182/bloodadvances.2021006440
Published: 2023
Includes: Supplemental data